KEGG   PATHWAY: nasi05216
Entry
nasi05216                   Pathway                                
Name
Thyroid cancer - Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
nasi05216  Thyroid cancer
nasi05216

Organism
Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise) [GN:nasi]
Gene
112403824  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X1 [KO:K05126] [EC:2.7.10.1]
112413291  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
112395739  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
112401754  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
112401747  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
112403492  TPR; nucleoprotein TPR isoform X1 [KO:K09291]
112409241  TFG; protein TFG isoform X1 [KO:K09292]
112402519  HRAS; GTPase HRas isoform X1 [KO:K02833]
112413065  NRAS; GTPase NRas [KO:K07828]
112391643  KRAS; GTPase KRas isoform X1 [KO:K07827]
112398096  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
112393112  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
112400165  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
112412232  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
112399342  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
112398911  PAX8; paired box protein Pax-8 isoform X1 [KO:K09293]
112396459  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
112411563  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
112413837  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
112397710  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
112401891  TP53; cellular tumor antigen p53 [KO:K04451]
112414074  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
112396403  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
112392793  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
112390848  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
112415661  BAX; apoptosis regulator BAX [KO:K02159]
112414038  BAK1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
112402084  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
112391413  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
112392355  CDH1; cadherin-1 [KO:K05689]
112405503  CTNNB1; catenin beta-1 [KO:K02105]
112399678  TCF7; transcription factor 7 isoform X1 [KO:K02620]
112399043  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
112406953  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
112397669  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
112397143  MYC; myc proto-oncogene protein isoform X1 [KO:K04377]
112402178  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
nasi03320  PPAR signaling pathway
nasi04010  MAPK signaling pathway
nasi04115  p53 signaling pathway
nasi04310  Wnt signaling pathway
nasi04520  Adherens junction
KO pathway
ko05216   
LinkDB

DBGET integrated database retrieval system